當前位置：BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 79935CD33– CHO K1 Recombinant Cell Line (High, Medium and Low Expression)
Anti-BCMA CAR /NFAT (Luciferase) Re
Anti-CD19 CAR / NFAT (Luciferase) R
Recombinant CD33-CHO K1 cell line stably expressing the full length human C33/Siglec-3 receptor (GenBank Accession: BC028152.1). Surface expression of CD33 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD33 expression (High(79935-H), Medium(79935-M), Low(799350L)) to mimic different stages of cancer target cells with various CD33 expression levels.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
化工儀器網